Chronic Mesenteric Artery Disease data elements

Description

Known atherosclerosis in any vascular territory

Data type

text

Description

Symptoms suggestive of mesenteric ischemia ● Abdominal fullness, bloating, discomfort after eating that ultimately results in “fear of food” ● Weight loss, anorexia, failure to thrive ● All associated with presence of atherosclerosis in other vascular beds or the presence of cardiac dysrhythmia (ie, atrial fibrillation) or severe left ventricular dysfunction

Data type

text

Description

Pain, bloating, early satiety following ingestion of food and/or liquids

Data type

boolean

Alias

UMLS CUI-1

C0740589

Description

Avoidance of eating because of predictable abdominal pain, often resulting in more frequent eating of small amounts of food

Data type

boolean

Alias

UMLS CUI-1

C0919597

Description

Specify amount of weight loss

Data type

float

Measurement units

• kg

Alias

UMLS CUI-1

C1262477

Description

The patient manifests malnutrition because of inadequate caloric intake to meet metabolic demands, as well as dehydration.

Data type

boolean

Alias

UMLS CUI-1

C0162429

Description

● Diarrhea ● Oily stool ● Floating stool

Data type

boolean

Alias

UMLS CUI-1

C0024523

Description

Describe the patient’s body habitus

Data type

integer

Alias

UMLS CUI-1

C1318474

Description

Estimate abdominal aortic diameter by palpation

Data type

float

Measurement units

• cm

Alias

UMLS CUI-1

C0579133

Description

Indicate the presence of abdominal bruit

Data type

boolean

Alias

UMLS CUI-1

C0221755

Description

Examine the lower rectum to check for abnormalities in the rectum and stool (hemoccult).

Data type

text

Alias

UMLS CUI-1

C1384593

Description

Occult blood present?

Data type

boolean

Alias

UMLS CUI-1

C0201811

Description

Amylase Indicate the following: ● Date of test ● Value ● Unit of measurement ● Normal range

Data type

float

Alias

UMLS CUI-1

C0201883

Description

Lipase Indicate the following: ● Date of test ● Value ● Unit of measurement ● Normal range

Data type

float

Alias

UMLS CUI-1

C0523940

Description

Stool fat content ● Microscopic: Indicate the number of stainable lipid globules per high-powered microscope field. ● Gravimetric: Indicate the collection period (number of days), reference range, and test result in grams of lipid per 24 h. ● Titrimetric

Data type

float

Alias

UMLS CUI-1

C0202012

Description

Fecal occult blood present?

Data type

boolean

Alias

UMLS CUI-1

C0201811

Description

Mesenteric Artery Duplex Ultrasound Date of procedure Operator name Peak systolic velocity measurements ● Aorta ● Celiac artery ● Superior mesenteric artery ● Inferior mesenteric artery Ratio of mesenteric artery to aorta peak systolic velocities: Record ratio for celiac, superior mesenteric, and inferior mesenteric arteries. Location of stenosis: ● Celiac artery ● Superior mesenteric artery ● Inferior mesenteric artery Category of stenosis: Specify for celiac, superior mesenteric, and inferior mesenteric arteries. Choose 1 of the following: ● 0–69% ● 70%–99% ● Occlusion

Data type

text

Description

Computed Tomographic Angiography Date of procedure Contrast used: ● Ionic contrast ● Nonionic contrast; specify: — Monomer — Dimer Contrast volume [ml] Artery imaged: ● Celiac artery ● Superior mesenteric artery ● Inferior mesenteric artery Location of stenosis Artery stenosis:Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Aneurysm: Dilation of a mesenteric artery to a diameter >=1.5 times the nondilated diameter Thickening of the small or large bowel wall: yes/no Free air in the abdomen: yes/no Mesenteric venous thrombosis: Patent venous opacification of the superior mesenteric vein and portal vein Pneumatosis coli: yes/no

Data type

text

Alias

UMLS CUI-1

C1536105

Description

Magnetic Resonance Angiography Date of procedure Contrast use: yes/no Artery imaged: ● Celiac artery ● Superior mesenteric artery ● Inferior mesenteric artery Location of stenosis Artery stenosis: Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Aorta: Identify atherosclerosis, stenosis, occlusion, and/or aneurysm of the abdominal aorta. Thickening of the small or large bowel wall: yes/no Free air in the abdomen: yes/no Mesenteric venous thrombosis: Patent venous opacification of the superior mesenteric vein and portal vein Pneumatosis coli: yes/no

Data type

text

Alias

UMLS CUI-1

C0243032

Description

Date of procedure Operator name Artery imaged: ● Celiac artery ● Superior mesenteric artery ● Inferior mesenteric artery Artery stenosis: Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Aorta: Identify atherosclerosis, stenosis, occlusion, and/or aneurysm of the abdominal aorta. Diffuse vasospasm: Indicate the presence or absence of vasospasm consistent with nonocclusive mesenteric ischemia. Mesenteric venous thrombosis: Indicate whether the superior mesenteric vein and portal vein are patent or occluded by thrombus.

Data type

text

Alias

UMLS CUI-1

C0002979

Description

Date of procedure Operator name Angioplasty/stenting Choose one: ● Balloon angioplasty alone ● Stent Balloon length [mm] Nominal balloon diameter: Indicate the diameter of the balloon at initial inflation and final inflation in millimeters. How many stents used (per artery)? ● 1 ● >1 Stent type: ● Balloon expandable ● Self-expanding ● Drug eluting ● Covered Stent brand name: Identify the brand name of the stent used. Stent model: Identify the model number of the stent used. Stent manufacturer Identify the manufacturer of the stent used. Stent length Indicate the length of the stent used in millimeters. Stent diameter Indicate the diameter of the stent used in millimeters. Target mesenteric artery Indicate whether the target vessel for the procedure is the celiac, superior mesenteric, and/or inferior mesenteric artery. Current procedure part of clinical trial Indicate whether the procedure is part of a clinical trial. Choose 1 of the following: ● Yes — If yes, indicate the trial type: X IDE X Postmarket approval X Other (specify) ● No Anesthesia Indicate if the patient received general anesthesia, conscious sedation, local anesthesia, or no anesthesia during the current procedure. Procedure Indications and Anatomic Variables Clinical indication ● Symptoms of mesenteric ischemia ● Weight loss ● Malnutrition ● Other Restenosis in target vessel after prior mesenteric artery stent Note if the indication for the current procedure is restenosis in the target mesenteric artery that was previously treated with angioplasty and/or a stent. Contrast volume Indicate the volume of iodinated contrast injected during the procedure in milliliters. Fluoroscopy time Indicate the total fluoroscopy time recorded during the procedure to the nearest 0.10 min. The time recorded should include the total time for the procedure. Procedure arterial access site Indicate the primary arterial access site used to perform the mesenteric artery stenting procedure. Note the location (right/left): ● Femoral ● Brachial ● Radial ● Axillary Arterial access closure method ● List methods and devices in chronological order of closure. ● Indicate the method used to achieve hemostasis: — Device — Nondevice (such as manual compression) Lesions Target lesion location Indicate the location of the target lesion. Visible thrombus present Indicate if the target lesion contains thrombus as assessed by baseline angiography and implied by the presence of filling defect. Calcification: Indicate if calcification is present. If present, specify the location. Choose 1 of the following: ● None ● Mild ● Moderate ● Severe Lesion length Indicate the length of the target lesion in millimeters as assessed by baseline angiography. Minimal luminal diameter Indicate the MLD of the target lesion in millimeters as assessed by baseline angiography. Diameter of distal mesenteric artery Indicate the diameter of the nontapering distal segment of the mesenteric artery measurement at the intended landing zone of the distal edge of the stent. Preprocedure percent stenosis of mesenteric artery: Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Lesion treatment incomplete or aborted: Indicate if the lesion treatment was incomplete or aborted. Choose 1 of the following: ● Yes — If yes, note reasons: X Failure to gain vascular access. X Failure to engage ostium with guide catheter X Unable to cross with guidewire X Unable to deploy stent X Failure to confirm significant stenosis X Unable to cross balloon X Cardiac ischemia X Unable to deploy device X Hypotension X Hypertension X Unable to deliver stent X Other ● No Embolic protection attempted: Indicate if the operator tried to use an EPD: ● Yes — If yes, indicate if predilatation before balloon or stent was performed or not. — If yes, list EPD in chronological order. Note if successfully deployed. ● No Stent malposition Indicate if the stent was deployed in a location or position other than that for which it was intended. Final minimal luminal diameter Indicate the final residual lumen diameter in millimeters. Final percent stenosis of mesenteric artery Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment How many stents used (per artery)? ● 1 ● >1

Data type

text

Description

Aortomesenteric Bypass Graft Surgery Date of procedure Proximal anastomosis: Indicate the location of proximal anastomosis with graft (ie, supraceliac aorta, iliac artery). Distal anastomosis: Indicate the location of distal anastomosis with graft (ie, mid-celiac artery, mid-SMA). Conduit: Indicate the type of graft material used for bypass (eg, synthetic, autologous). Mesenteric Endarterectomy Date of procedure

Data type

text

Alias

UMLS CUI-1

C0581603

Description

Indicate the period at which outcome measures are assessed

Data type

integer

Alias

UMLS CUI-1

C2986292

Description

Indicate postoperative clinical events or conditions associated with an endovascular procedure. Choose all that apply: ● Pseudoaneurysm ● AV fistula ● Hematoma ● Dissection ● Vessel thrombosis ● Vessel perforation ● Atheromatous embolization ● Contrast nephropathy ● Contrast hypersensitivity ● Infection ● Requirement of intervention to prevent permanent impairment/damage

Data type

text

Alias

UMLS CUI-1

C0009566

UMLS CUI-2

C2936204

Description

Indicate complications of open surgery. Choose all that apply: ● Major complication: — Death — MI (also see cardiovascular complications below) — Stroke (ischemic, hemorrhagic, unknown type) ● Other life-threatening major complication (specify): — Prolonged hospitalization — Persistent or significant disability or incapacity — Vessel thrombosis — Vessel rupture — Seroma — Hematoma — Renal failure — Bowel infarction — Other end-organ damage — Pneumonia — DVT — Graft thrombosis — Atheromatous embolization — Requirement of intervention to prevent permanent impairment/damage — Infection ● Minor complication (specify)

Data type

text

Alias

UMLS CUI-1

C0009566

UMLS CUI-2

C0348025

Description

Indicate the length of stay in the hospital in number of days.

Data type

integer

Measurement units

• days

Alias

UMLS CUI-1

C0023303

Description

Indicate the patient’s discharge status. Choose 1 of the following: ● Discharged to home or self-care — This includes discharge to home; jail or law enforcement; home on oxygen if DME only; any other DME only; group home, foster care, and other residential care arrangements; outpatient programs such as partial hospitalization or outpatient chemical dependency programs; assisted living facilities that are not state designated. ● Discharged/transferred to short-term general hospital for inpatient care ● Discharged/transferred to an SNF with Medicare certification in anticipation of skilled care ● Discharged/transferred to an ICF ● Discharged/transferred to standard rehabilitation facility ● Discharged/transferred to ventilator rehabilitation facility ● Discharged/transferred to another type of healthcare institution other than the above ● Patient died

Data type

text

Alias

UMLS CUI-1

C0586514

Description

Verbal and written medication instructions provided to patient and/or family

Data type

text

Alias

UMLS CUI-1

C2064717

Description

Verbal and written instructions provided to patient and/or family (by physician or nurse) regarding new or worsening symptoms and when to call the physician

Data type

text

Description

Advice given or discussion held with patient and/or family about diet counseling in relation to lowering cardiovascular risk. May include ● Sodium restriction ● Fluid restriction ● Referral to dietitian for weight management and/or advanced nutritional instruction. ● Other (specify)

Data type

text

Alias

UMLS CUI-1

C0204932

Description

Advice given or discussion held with patient (by physician, nurse, or other personnel) about the importance of stopping smoking. May include ● Counseling (may be basic or advanced) ● Written materials ● Referral to smoking cessation program ● Drugs to help with smoking cessation

Data type

text

Alias

UMLS CUI-1

C1095963

Description

Advice given or discussion held with patient and/or family about activity level and restrictions in activity and/or exercise recommendations

Data type

text

Description

Documentation of evaluation of patient following discharge. Indicate all of the following that apply: ● Physical examination ● Imaging (eg, ultrasound, MR, CT)

Data type

text

Description

Documentation of evaluation of patient after discharge. Indicate all of the following that apply ● Physical examination ● Imaging (eg, ultrasound, MR, CT)

Data type

text

Description

Indicate the period at which outcome measures are assessed. Choose all that apply: ● 1 mo ● 3 mo ● 6 mo ● 1 y

Data type

text

Alias

UMLS CUI-1

C2986292

Description

Assess recurrent signs and symptoms of mesenteric disease: ● Appetite ● Caloric intake ● Nutritional status ● Presence or absence of postprandial abdominal pain ● Food avoidance/tolerance ● Weight loss/gain

Data type

text

Alias

UMLS CUI-1

C0679830

Description

Adverse events

Data type

integer

Alias

UMLS CUI-1

C0877248